News

AO-VISION Symposium 2026 – replay available

Adressing a major unmet need for validating novel treatments for RP: biomarkers that are sensitive enough to the slowly progressing disease.

Retinitis Pigmentosa: Advanced imaging biomarkers

Adressing a major unmet need for validating novel treatments for RP: biomarkers that are sensitive enough to the slowly progressing disease.

Exciting news from the Lions Eye Institute in Perth, Australia!

Thanks to the generous support of the Channel 7 telethon7 Trust, Lions Eye Institute has just welcomed the RTX1 retinal camera…

New Review Article on Retinal Vascular Remodeling Assessed with RTX1

    In a recently published review article, a team of ophthalmologists and cardiologists reviewed studies…

Cone photoreceptor analysis got faster, more objective, and scalable

Characterizing the cone mosaic from adaptive optics images has long been a bottleneck. Time-consuming, and difficult to standardize. To change that, Erasmus MC and Imagine Eyes introduce AOBOX...

Celebrating 2025 milestones with our community

As we step into 2026, we want to express our heartfelt gratitude to the incredible community of researchers, clinicians,…

Introducing AObox: AI-Powered Cone Analysis for rtx1

Developed by Erasmus MC Rotterdam, AObox brings ready-to-use AI models to AO clinical studies, and provides cone density heatmaps and quantitative metrics directly from AO images and montages.

Retinal Microvasculature as a Window into Systemic Health

CKD, cardiovascular risks, cognitive decline. Micron-precision vascular assessments open new avenues for clinical research.

Imagine Eyes installs a breakthrough cellular-resolution retinal tomograph at Emory University

Professor Michael Girard and his team adopt M2OCT to develop ultra-precise AI biomarkers of neurodegenerative diseases in the eye and brain...